a double-blind cross-over clinical trial was performed to compare clinical effectiveness of indomethacin ( 3 x 25 mg/day ) alone to that of a combination of indomethacin + sodium-salycylate ( 3 x 25 mg/day and 3 x 250 mg/day , respectively ) in rheumatoid arthritis .
C0021246
indomethacin
C0003873
rheumatoid arthritis